Price Alert

Black Diamond Therapeutic... (BDTX)

NASDAQ: BDTX · Real-Time Price · USD

2.76

-0.03 (-1.08%)

At close: Aug 15, 2025, 3:59 PM

2.77

0.36%

After-hours: Aug 15, 2025, 07:30 PM EDT

Black Diamond Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	29.99M	98.42M	36.44M	23.43M	32.81M	25.42M	56.22M	57.98M	41.89M	39.14M	34.31M	53.96M	55.88M	54.08M	65.8M	46.6M	37.32M	14.11M
Short-Term Investments	n/a	53.98M	62.14M	89.26M	90.16M	89.78M	75.18M	86.28M	47.64M	64.22M	88.49M	90.22M	105.01M	125.66M	143.99M	188.41M	226.15M	275.95M
Long-Term Investments	n/a	n/a	n/a	n/a	822K	819K	823K	819K	1.23M	1.17M	1.17M	1.17M	1.17M	1.22M	143.99K	1.22M	1.22M	1.22M
Other Long-Term Assets	985K	1.03M	1.07M	1.12M	337K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	10K	10K	7.01M	99K	98K	100K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	116.73M	3.28M	2.6M	2.86M	3.78M	3.61M	n/a	2.79M	3.46M	4.61M	4.9M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	146.73M	155.68M	101.18M	115.54M	126.75M	118.81M	134.03M	147.05M	92.99M	107.98M	127.71M	150.98M	168.56M	188.3M	209.79M	241.55M	270.95M	297.35M
Property-Plant & Equipment	18.67M	19.54M	20.4M	21.24M	22.07M	22.9M	23.71M	24.51M	25.66M	26.44M	27.38M	28.27M	29.1M	29.95M	30.74M	31.26M	15.61M	14.59M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.66M	20.57M	21.46M	22.36M	23.23M	23.71M	24.53M	25.33M	26.89M	27.61M	28.55M	29.44M	30.28M	31.18M	37.9M	32.58M	16.93M	15.91M
Total Assets	166.38M	176.25M	122.64M	137.9M	149.99M	142.52M	158.57M	172.38M	119.88M	135.58M	156.25M	180.42M	198.83M	219.48M	247.68M	274.13M	287.88M	313.26M
Account Payables	771K	2.63M	4.01M	1.97M	763K	1.18M	2.32M	694K	2.74M	3.05M	1.88M	5.76M	2.22M	1.88M	4.11M	4.86M	5.03M	4.62M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.04M	-2.98M	n/a	n/a	n/a	n/a	n/a	19.2M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	16.03M	n/a	8.79M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	16.8M	16.85M	20.57M	20.8M	18.44M	16.85M	19.65M	15.07M	13.9M	12.85M	15.26M	21.14M	19.71M	19.47M	23.64M	26.36M	23.49M	18.7M
Long-Term Debt	16.97M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	16.97M	17.88M	18.78M	19.67M	20.53M	21.36M	22.18M	23M	23.78M	24.55M	25.3M	26.04M	26.76M	27.45M	28.14M	28.82M	13.38M	13.8M
Total Liabilities	33.77M	34.73M	39.35M	40.47M	38.97M	38.22M	41.83M	38.06M	37.68M	37.39M	40.56M	47.19M	46.46M	46.92M	491.5M	55.18M	36.86M	32.51M
Total Debt	16.97M	21.59M	22.19M	23M	23.78M	24.55M	25.3M	26.04M	26.76M	27.45M	28.14M	28.82M	28.85M	28.25M	28.46M	28.82M	13.86M	14.23M
Common Stock	7K	7K	7K	7K	7K	7K	7K	7K	5K	5K	5K	5K	5K	5K	5K	5K	5K	5K
Retained Earnings	-441.13M	-430.56M	-487.11M	-471.12M	-455.56M	-435.66M	-417.43M	-398.02M	-375.02M	-355.86M	-334.99M	-313.91M	-292.26M	-269.33M	-243.82M	-217.95M	-182.88M	-148.53M
Comprehensive Income	-25K	-19K	24K	107K	-115K	-95K	-27K	-364K	-661K	-1.18M	-1.82M	-2.49M	-2.29M	-1.77M	-414K	143K	211K	335K
Shareholders Equity	132.61M	141.52M	83.28M	97.43M	111.02M	104.31M	116.74M	134.32M	82.2M	-355.86M	-334.99M	133.23M	152.37M	172.56M	-243.82M	218.95M	251.02M	280.75M
Total Investments	n/a	53.98M	62.14M	89.26M	90.98M	90.6M	76M	86.28M	47.64M	64.22M	88.49M	90.22M	105.01M	125.66M	143.99K	188.41M	226.15M	275.95M